A call to arms: Economic barriers to optimal dialysis care

Peritoneal Dialysis International

Volumn 20, Issue 1, 2000, Pages 7-12

  McFarlane, Philip A ^a   Mendelssohn, David C ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CONTINUING EDUCATION; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; DIALYSIS; EDITORIAL; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; KIDNEY FAILURE; MEDICAL RESEARCH; NEPHROLOGY; PATIENT REFERRAL; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0034080790     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080002000102     Document Type: Editorial

References (45)

1. Cheng IK. Peritoneal dialysis in Asia. Perit Dial Int 1996; 16(Suppl 1):S381-5.
2. Rao M, Juneja R, Shirly RB, Jacob CK. Haemodialysis for end-stage renal disease in Southern India - a perspective from a tertiary referral care centre. Nephrol Dial Transplant 1998; 13:2494-500.
3. Mittal S, Kher V, Gulati S, Agarwal LK, Arora P. Chronic renal failure in India. Ren Fail 1997; 19:763-70.
4. Barton EN, Williams W, Morgan AG, Burden RP. A prospective study of ward referrals for renal disease at a Jamaican and a United Kingdom hospital. West Indian Med J 1996; 45:110-12.
5. Canadian Organ Replacement Register (CORR). 1999 Annual Report. Ottawa: Canadian Institute for Health Information, 1999.
6. United States Renal Data System. USRDS 1999 Annual data report. Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1999.
7. Sesso R, Fernandes PF, Ancao M, Drummond M, Draibe S, Sigulem D, et al. Acceptance for chronic dialysis treatment: insufficient and unequal. Nephrol Dial Transplant 1996; 11:982-6.
8. Giuseppe P, Mario S, Barbara PG, Paola M, Pacitti A, Antonio M, et al. Elderly patients on dialysis: epidemiology of an epidemic. Nephrol Dial Transplant 1996; 11(Suppl 9):26-30.
9. Mendelssohn DC, Kua BT, Singer PA. Referral for dialysis in Ontario. Arch Intern Med 1995; 155:2473-8.
10. Challah S, Wing AJ, Bauer R, Morris RW, Schroeder SA. Negative selection of patients for dialysis and transplantation in the United Kingdom. Br Med J (Clin Res Ed) 1984; 288:1119-22.
11. Taube DH, Winder EA, Ogg CS, Bewick M, Cameron JS, Rudge CJ, et al. Successful treatment of middle aged and elderly patients with end stage renal disease. Br Med J (Clin Res Ed) 1983; 286:2018-20.
12. Moulton LH, Port FK, Wolfe RA, Foxman B, Guire KE. Patterns of low incidence of treated end-stage renal disease among the elderly. Am J Kidney Dis 1992; 20:55-62.
13. Held PJ, Blagg CR, Liska DW, Port FK, Hakim R, Levin N. The dose of hemodialysis according to dialysis prescription in Europe and the United States. Kidney Int Suppl 1992; 38:S16-21.
14. Shaldon S. Adequacy of long-term hemodialysis. Curr Opin Nephrol Hypertens 1992; 1:197-202.
15. Locatelli F, Marcelli D, Conte F. Dialysis patient outcomes in Europe vs the USA. Why do Europeans live longer? Nephrol Dial Transplant 1997; 12:1816-19.
16. Mendelssohn DC and Blake PG. Sifting sand: dialysis funding and modality distribution in Ontario. Nephrol News Issues 1999; 13:31-7.
17. Garella S. The costs of dialysis in the USA. Nephrol Dial Transplant 1997; 12:10-21.
18. Venkataraman V and Nolph KD. Socioeconomic aspects of peritoneal dialysis in North America: role of non medical factors in the choice of dialysis. Perit Dial Int 1999; 19(Suppl 2):S419-22.
19. Levinsky NG. The organization of medical care. Lessons from the Medicare End Stage Renal Disease Program. N Engl J Med 1993; 329:1395-9.
20. Inglehart JK. The American health care system. The End Stage Renal Disease Program. N Engl J Med 1993; 328:366-71.
21. Garg PP, Frick KD, Diener-West M, Powe NR. Effect of the ownership of dialysis facilities on patient's survival and referral for transplantation. N Engl J Med 1999; 341:1653-60.
22. Levinsky NG. Quality and equity in dialysis and renal transplantation. N Engl J Med 1999; 341:1691-3.
23. Nissenson AR, Prichard SS, Cheng IK, Gokal R, Kubota M, Maiorca R, et al. Non-medical factors that impact on ESRD modality selection. Kidney Int Suppl 1993; 40:S120-7.
24. Nissenson AR, Prichard SS, Cheng IK, Gokal R, Kubota M, Maiorca R, et al. ESRD modality selection into the 21st century: the importance of non medical factors. ASAIO J 1997; 43:143-50.
25. Van Biesen W, Wiedemann M, Lameire N. End stage renal disease treatment: a European perspective. J Am Soc Nephrol 1998; 12(Suppl):S55-62.
26. Mendelssohn DC and Chery A. Dialysis utilization in the Toronto region from 1981 to 1992. Toronto Region Dialysis Committee. Can Med Assoc J 1994; 150: 1099-105.
27. United States Renal Data System. The USRDS Dialysis Morbidity and Mortality Study: Wave 2. Am J Kidney Dis 1997; 30(Suppl):S67-85.
28. Blake PG. Factors affecting international utilization of peritoneal dialysis: implications for increasing utilization in the United States. Semin Dial 1999; 12:365-9.
29. Bloembergen WE, Port FK, Mauger EA, Wolfe RA. A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1995; 6:177-83.
30. Bloembergen WE, Port FK, Mauger EA, Wolfe RA. A comparison of cause of death between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1995; 6:184-91.
31. Fenton SS, Schaubel DE, Desmeules M, Morrison HI, Mao Y, Copleston P, et al. Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis 1997; 30:334-42.
32. Jung B, Blake PG, Mehta RL, Mendelssohn DC. Attitudes of Canadian nephrologists toward dialysis modality selection. Perit Dial Int 1999; 19:263-8.
33. Prichard SS. Treatment modality selection in 150 consecutive patients starting ESRD therapy. Perit Dial Int 1996; 16:69-72.
34. Lameire N, Van Biesen W, Dombros N, Dratwa M, Faller B, Gahl GM, et al. The referral pattern of patients with ESRD is a determinant in the choice of dialysis modality. Perit Dial Int 1997; 17(Suppl 2):S161-6.
35. Luehmann D and Cosentino L. Safety of dialyzer reuse with Renalin: the untold story. Dial Transplant 1994; 23:248-58.
36. Collins AJ, Ma JZ, Constantini EG, Everson SE. Dialysis unit and patient characteristics associated with reuse practices and mortality: 1989-1993. J Am Soc Nephrol 1998; 9:2108-17.
37. Bruns FJ, Seddon P, Saul M, Zeidel ML. The cost of caring for end-stage kidney disease patients: an analysis based on hospital financial transaction records. J Am Soc Nephrol 1998; 9:884-90.
38. Bleyer AJ, Rocco MV, Burkart JM. The costs of hospitalizations due to hemodialysis access management. Nephrol News Issues 1995; 9:19-22.
39. Feldman HI, Held PJ, Hutchinson JT, Stoiber E, Hartigan MF, Berlin JA. Hemodialysis vascular access morbidity in the United States. Kidney Int 1993; 43:1091-6.
40. National Kidney Foundation-Dialysis Outcomes Quality Initiative. NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis 1997; 30(Suppl): S150-91.
41. Jindal KK, Ethier JH, Lindsay RM, Barre PE, Kappel JE, Carlisle EJ, et al. Clinical practice guidelines for vascular access. J Am Soc Nephrol 1999; 10(Suppl): S297-305.
42. Schwab SJ. Improving access patency: pre-end-stage renal disease strategies. J Am Soc Nephrol 1998; 9(Suppl):S124-9.
43. Consensus Development Conference Panel. Morbidity and mortality of renal dialysis: an NIH consensus conference statement. Ann Intern Med 1994; 121:62-70.
44. Obrador GT and Pereira BJ. Early referral to the nephrologist and timely initiation of renal replacement therapy: a paradigm shift in the management of patients with chronic renal failure. Am J Kidney Dis 1998; 31:398-417.
45. Obrador GT, Arora P, Kausz AT, Pereira BJ. Pre-end stage renal disease care in the United States: a state of disrepair. J Am Soc Nephrol 1998; 12(Suppl):S44-54.